U.S. Securities & Exchange Commission
SEC Seal
Home | Previous Page
U.S. Securities and Exchange Commission

U.S. SECURITIES AND EXCHANGE COMMISSION

Litigation Release No. 20880 / February 4, 2009

SEC v. Biovail Corporation, Eugene Melnyk, Brian Crombie, John Miszuk, and Kenneth G. Howling, 08 Civ. 02979 (LAK) (S.D.N.Y. filed March 24, 2008)

SEC Obtains Stipulated Judgment Against Former Biovail CEO On Stock Accumulation Disclosure Charges

Eugene Melnyk Stipulates to a Judgment Imposing a $1 Million Civil Penalty

The Securities and Exchange Commission announced that the United States District Court has entered a stipulated judgment against Eugene Melnyk, Biovail Corporation's former chairman and chief executive officer, with respect to violations of the stock accumulation disclosure provisions of the federal securities laws alleged by the Commission in a civil enforcement action filed in March 2008. The Commission's securities fraud charges against Melnyk in that action remain pending.

The Commission's complaint alleges, among other things, that Melnyk violated the stock accumulation disclosure provisions by failing to include in his Schedule 13D filings Biovail shares held in several off-shore trusts that Melnyk controlled. The complaint further alleges that, because Melnyk exercised both investment and trading authority over the shares in the trusts, Melnyk was a beneficial owner of the securities and was required to disclose the trust holdings in his Schedule 13D filings with the Commission.

The Commission's complaint also alleges that Melnyk, other senior Biovail executives, and Biovail violated the antifraud and other provisions of the securities laws. Biovail previously settled with the Commission by consenting to a judgment that, among other things, permanently enjoined it from violating antifraud and other provisions of the federal securities laws, imposed a $10 million civil penalty, and ordered it to pay disgorgement of $1. The Commission's allegations of violations of the antifraud and other provisions of the federal securities laws remain pending against Melnyk and three other former Biovail executives: former chief financial officer Brian Crombie; former controller John Miszuk; and former chief financial officer Kenneth G. Howling.

The stipulated judgment against Melnyk permanently enjoins him from future violations of Section 13(d) of the Exchange Act and Rules 13d-1 and 13d-2 and imposes a civil penalty in the amount of $1,000,001. It states explicitly that the securities fraud charges against Melnyk remain pending and are not resolved by the stipulated judgment announced today.

For further information, see Litigation Release No. 20506 (March 24, 2008).

 

http://www.sec.gov/litigation/litreleases/2009/lr20880.htm


Modified: 02/04/2009